September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Mark Wildgust: Forefront of Innovation – The Story of Developing Bispecific Antibodies
Apr 27, 2025, 12:47

Mark Wildgust: Forefront of Innovation – The Story of Developing Bispecific Antibodies

Mark Wildgust, The Janssen Pharmaceutical Companies of Johnson and Johnson, shared a post on X:

“Looking forward to sharing the story of how the Johnson and Johnson Innovative Medicine team working in partnership with the medical community, Saad Z. Usmani Marivi Mateos Byoung Chul Cho, has been at the forefront of innovation in developing bispecifics in oncology.

Register to join.”

More posts featuring Johnson and Johnson Innovative Medicine.